Richard C. Pasternak

39.8k total citations · 9 hit papers
93 papers, 28.3k citations indexed

About

Richard C. Pasternak is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Richard C. Pasternak has authored 93 papers receiving a total of 28.3k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Surgery, 37 papers in Cardiology and Cardiovascular Medicine and 30 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Richard C. Pasternak's work include Lipoproteins and Cardiovascular Health (38 papers), Health Systems, Economic Evaluations, Quality of Life (20 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers). Richard C. Pasternak is often cited by papers focused on Lipoproteins and Cardiovascular Health (38 papers), Health Systems, Economic Evaluations, Quality of Life (20 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (20 papers). Richard C. Pasternak collaborates with scholars based in United States, Germany and Australia. Richard C. Pasternak's co-authors include Scott M. Grundy, Luther T. Clark, Donald B. Hunninghake, Neil J. Stone, Sidney C. Smith, James I. Cleeman, C. Noel Bairey Merz, James M. McKenney, Margo A. Denke and Diane M. Becker and has published in prestigious journals such as New England Journal of Medicine, Circulation and Annals of Internal Medicine.

In The Last Decade

Richard C. Pasternak

92 papers receiving 26.9k citations

Hit Papers

Detection, evaluation, and treatment of high blood choles... 1999 2026 2008 2017 2002 2004 2006 2004 1999 2.5k 5.0k 7.5k 10.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    2002 10.7k citations Scott M. Grundy, Luther T. Clark et al. profile →
  2. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
    2004 5.3k citations Scott M. Grundy, James I. Cleeman et al. Circulation profile →
  3. AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
    2006 1.6k citations Sidney C. Smith, Jerilyn K. Allen et al. Circulation profile →
  4. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
    2004 1.2k citations Scott M. Grundy, James I. Cleeman et al. Journal of the American College of Cardiology profile →
  5. Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations
    1999 994 citations Scott M. Grundy, Richard C. Pasternak et al. Circulation profile →
  6. ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins
    2002 837 citations Richard C. Pasternak, C. Noel Bairey Merz et al. Circulation profile →
  7. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update
    2001 536 citations Sidney C. Smith, Steven N. Blair et al. Journal of the American College of Cardiology profile →
  8. AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
    2006 517 citations Sidney C. Smith, Jerilyn K. Allen et al. Journal of the American College of Cardiology profile →
  9. AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update
    2001 504 citations Steven N. Blair, Robert O. Bonow et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard C. Pasternak United States 48 11.5k 10.0k 9.4k 3.6k 3.4k 93 28.3k
Donald B. Hunninghake United States 47 11.3k 1.0× 7.5k 0.7× 9.4k 1.0× 3.1k 0.9× 3.5k 1.0× 167 26.4k
Patrick E. McBride United States 37 10.5k 0.9× 12.5k 1.3× 7.8k 0.8× 3.4k 0.9× 3.7k 1.1× 119 29.9k
Luther T. Clark United States 38 8.6k 0.8× 7.6k 0.8× 7.5k 0.8× 3.1k 0.9× 2.6k 0.7× 102 22.5k
Kalevi Pyörälà Finland 77 12.7k 1.1× 12.8k 1.3× 15.1k 1.6× 4.6k 1.3× 3.6k 1.1× 231 34.4k
Lars Wilhelmsen Sweden 82 8.9k 0.8× 12.6k 1.3× 8.1k 0.9× 3.6k 1.0× 2.6k 0.8× 394 31.7k
Curt D. Furberg United States 96 8.8k 0.8× 17.5k 1.8× 8.9k 1.0× 3.6k 1.0× 3.7k 1.1× 340 39.0k
Robert H. Eckel United States 60 9.5k 0.8× 8.6k 0.9× 7.1k 0.8× 3.5k 1.0× 2.9k 0.8× 168 28.4k
Hans Wedel Sweden 83 14.7k 1.3× 21.7k 2.2× 15.0k 1.6× 3.2k 0.9× 3.2k 0.9× 268 44.2k
James Shepherd United Kingdom 62 19.9k 1.7× 8.3k 0.8× 11.0k 1.2× 5.0k 1.4× 5.8k 1.7× 175 33.0k
Guy De Backer Belgium 64 7.5k 0.7× 12.3k 1.2× 5.6k 0.6× 1.8k 0.5× 2.7k 0.8× 304 24.3k

Countries citing papers authored by Richard C. Pasternak

Since Specialization
Citations

This map shows the geographic impact of Richard C. Pasternak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard C. Pasternak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard C. Pasternak more than expected).

Fields of papers citing papers by Richard C. Pasternak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard C. Pasternak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard C. Pasternak. The network helps show where Richard C. Pasternak may publish in the future.

Co-authorship network of co-authors of Richard C. Pasternak

This figure shows the co-authorship network connecting the top 25 collaborators of Richard C. Pasternak. A scholar is included among the top collaborators of Richard C. Pasternak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard C. Pasternak. Richard C. Pasternak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kizer, Jorge R., Christopher Madias, Carl J. Vaughan, et al.. (2010). Relation of Different Measures of Low-Density Lipoprotein Cholesterol to Risk of Coronary Artery Disease and Death in a Meta-Regression Analysis of Large-Scale Trials of Statin Therapy. The American Journal of Cardiology. 105(9). 1289–1296. 39 indexed citations
2.
Maccubbin, Darbie, Michael J. Koren, Michael Davidson, et al.. (2009). Flushing Profile of Extended-Release Niacin/Laropiprant Versus Gradually Titrated Niacin Extended-Release in Patients With Dyslipidemia With and Without Ischemic Cardiovascular Disease. The American Journal of Cardiology. 104(1). 74–81. 57 indexed citations
3.
Smith, Sidney C., Jerilyn K. Allen, Steven N. Blair, et al.. (2006). AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update. Circulation. 113(19). 2363–2372. 1611 indexed citations breakdown →
4.
Rigotti, Nancy A., Anne N. Thorndike, Susan Regan, et al.. (2006). Bupropion for Smokers Hospitalized with Acute Cardiovascular Disease. The American Journal of Medicine. 119(12). 1080–1087. 115 indexed citations
5.
Smith, Sidney C., Jerilyn K. Allen, Steven N. Blair, et al.. (2006). AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update. Journal of the American College of Cardiology. 47(10). 2130–2139. 517 indexed citations breakdown →
6.
Grundy, Scott M., James I. Cleeman, C. Noel Bairey Merz, et al.. (2004). Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Journal of the American College of Cardiology. 44(3). 720–732. 1185 indexed citations breakdown →
7.
8.
Januzzi, James L. & Richard C. Pasternak. (2002). Depression, hostility, and social isolation in patients with coronary artery disease. Current Treatment Options in Cardiovascular Medicine. 4(1). 77–85. 11 indexed citations
9.
Cheitlin, Melvin D., Gary Gerstenblith, William R. Hazzard, et al.. (2001). Do Existing Databases Answer Clinical Questions about Geriatric Cardiovascular Disease and Stroke?. The American Journal of Geriatric Cardiology. 10(4). 207–223. 16 indexed citations
10.
Smith, Sidney C., Steven N. Blair, Robert O. Bonow, et al.. (2001). AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update. Journal of the American College of Cardiology. 38(5). 1581–1583. 536 indexed citations breakdown →
11.
Januzzi, James L., Theodore A. Stern, Richard C. Pasternak, & Roman W. DeSanctis. (2000). The Influence of Anxiety and Depression on Outcomes of Patients With Coronary Artery Disease. Archives of Internal Medicine. 160(13). 1913–1913. 229 indexed citations
12.
Pasternak, Richard C., Scott M. Grundy, Daniel Levy, & Paul D. Thompson. (1996). Task force 3. Spectrum of risk factors for coronary heart disease. Journal of the American College of Cardiology. 27(5). 978–990. 65 indexed citations
13.
Swan, H.J.C., Michael H. Davidson, Raymond J. Gibbons, et al.. (1994). Preventive cardiology and atherosclerotic disease. Journal of the American College of Cardiology. 24(3). 838–838. 4 indexed citations
14.
Stone, Peter H., et al.. (1993). Natural history of coronary atherosclerosis using quantitative angiography in men, and implications for clinical trials of coronary regression. The American Journal of Cardiology. 71(10). 766–772. 32 indexed citations
15.
Krumholz, Harlan M., Pamela S. Douglas, Michael S. Lauer, & Richard C. Pasternak. (1992). Selection of Patients for Coronary Angiography and Coronary Revascularization Early after Myocardial Infarction: Is There Evidence for a Gender Bias?. Annals of Internal Medicine. 116(10). 785–790. 242 indexed citations
16.
Reis, Gregg J., David I. Silverman, Mary Ellen Sipperly, et al.. (1990). Effects of two types of fish oil supplements on serum lipids and plasma phospholipid fatty acids in coronary artery disease. The American Journal of Cardiology. 66(17). 1171–1175. 42 indexed citations
17.
Ferguson, James J., et al.. (1989). Significance of nitroglycerin-induced hypotension with inferior wall acute myocardial infarction. The American Journal of Cardiology. 64(5). 311–314. 43 indexed citations
18.
Alderman, James, Gregory Gabliani, Carolyn H. McCabe, et al.. (1987). Incidence and management of limb ischemia with percutaneous wire-guided intraaortic balloon catheters. Journal of the American College of Cardiology. 9(3). 524–530. 67 indexed citations
19.
20.
Hong, Robert, Jonathan D. Licht, Jeanne Y. Wei, et al.. (1986). Elevated CK-MB with normal total creatine kinase in suspected myocardial infarction: Associated clinical findings and early prognosis. American Heart Journal. 111(6). 1041–1047. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donald B. Hunninghake Breakdown of academic impact, for papers by Patrick E. McBride Breakdown of academic impact, for papers by Luther T. Clark Breakdown of academic impact, for papers by Kalevi Pyörälà Breakdown of academic impact, for papers by Lars Wilhelmsen Breakdown of academic impact, for papers by Curt D. Furberg Breakdown of academic impact, for papers by Robert H. Eckel Breakdown of academic impact, for papers by Hans Wedel Breakdown of academic impact, for papers by James Shepherd Breakdown of academic impact, for papers by Guy De Backer
Rankless by CCL
2026